# Causeway Sensors

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/causeway-sensors

- Industry: Medical Devices & Equipment
- Headquarters: Belfast, UK
- Website: www.causewaysensors.com
- Total disclosed funding: $0.8M
- Latest round: Seed (Jun 10, 2016)
- Investors on record: 2

## About

Causeway Sensors Ltd. develops advanced monitoring solutions for bioprocessing, focusing on real-time measurement technologies that enhance efficiency and accuracy in biopharmaceutical production.Founded in 2013 and headquartered in Belfast, UK, Causeway Sensors Ltd. specializes in bioprocess monitoring solutions. The company has undergone strategic shifts to focus on developing its flagship device for real-time bioreactor data. The firm completed four deals, with its most recent funding round occurring on January 6, 2022, raising GBP 1.55 million led by Kernel Capital and QUBIS Limited. The total funds raised amount to GBP 1.55 million, valuing the company at GBP 8.45 million post-money. The founder, Robert Pollard, has a background in the tech industry, though further details on prior ventures are not available.Causeway Sensors Ltd. specializes in the development of advanced bioprocess monitoring solutions, primarily through their flagship product, a compact device designed for real-time measurement directly from bioreactor samples. This innovative technology enables users to collect at-line, real-time bioprocess data, specifically targeting applications such as IgG quantification, which is critical in the biopharmaceutical production process. The device is engineered to enhance efficiency and accuracy in bioproduction environments, providing manufacturers with essential insights into their processes. The company primarily serves clients within the biopharmaceutical industry, including contract manufacturing organizations and research institutions. Its market presence extends across various regions, notably North America, Europe, and Asia, where the demand for real-time data solutions in bioprocessing is growing.Causeway Sensors Ltd. generates revenue through direct sales and partnerships within the biopharmaceutical sector. Clients engage in transactions primarily on a B2B basis, purchasing technological solutions to improve their production processes. Revenue is derived from the sale of their proprietary measurement devices, as well as potential subscription models for ongoing software support and data analytics services. The company focuses on establishing long-term partnerships with organizations in need of bioprocessing solutions, allowing for customized service plans that align with clients' operational needs. While specific pricing details for individual products and services are not disclosed, the firm’s offerings are designed to meet the diverse requirements of its client base in the rapidly evolving biopharmaceutical market.In January 2022, Causeway Sensors Ltd. raised GBP 1.55 million in venture financing, which will be utilized to support the development of upcoming products, including enhancements to their real-time measurement device. The company is planning to expand its market presence into new geographic regions such as South America and Australia by the end of 2023. The recent funding will facilitate this expansion and further product development, aligning with their strategy to cater to the growing demand in the biopharmaceutical sector.

## Funding rounds

- Seed, Jun 10, 2016, $0.8M — Kernel Capital, Qubis

## Investors

- Kernel Capital (https://capitalatlas.ai/funds/kernel-capital) — Seed
- Qubis (https://capitalatlas.ai/funds/qubis) — Seed